HERON THERAPEUTICS, INC. /DE/ Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $3.10 million as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2022-02-28
- 2021-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $3.10M.
- 2020-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $4.27M.
- 2019-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $2.97M.
- 2019-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $2.95M.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2021-12-31 | $3.10M 10-K · filed 2022-02-28 |
| 2020-12-31 | $4.27M 10-K · filed 2021-02-24 |
| 2019-12-31 | $2.97M 10-K · filed 2020-03-02 |
| 2019-09-30 | $2.95M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.92M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $2.90M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |